Physician profile
Ming Yang
NPI 1598031296
$792.17
in general payments reported to CMS, 2019-2025
17 companies · $282 in 2025
The $282 reported for 2025 was less than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.64 · 2022: $55.83 · 2023: $232 · 2024: $209 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $626 · Education: $96.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $625.89 |
| Education | $96.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $206.75 | 2024-2025 | |
| Novo Nordisk INC | $96.81 | 2023 | Sogroya |
| Tandem Diabetes Care, INC. | $66.35 | 2022-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Tolmar, INC. | $56.06 | 2024-2025 | Fensolvi |
| Eton Pharmaceuticals, INC. | $47.72 | 2022-2025 | Increlex, Khindivi, Alkindi |
| Abbvie INC. | $45.40 | 2024-2025 | |
| Beta Bionics, INC. | $43.24 | 2023 | Ilet Bionic Pancreas |
| Dexcom, INC. | $41.35 | 2021-2023 | Dexcom G6 Transmitter |
| Medtronic, INC. | $33.33 | 2023-2025 | Inpen Smart Insulin Delivery System, Minimed 780g |
| Sanofi-Aventis U.S. LLC | $24.62 | 2025 | |
| Mannkind Corporation | $23.40 | 2025 | |
| Sequel Med Tech, LLC | $23.22 | 2025 | Twiist |
| Rhythm Pharmaceuticals, INC. | $20.78 | 2025 | Imcivree |
| Abbott Laboratories | $17.22 | 2024 | Freestyle Libre 3 |
| Xeris Pharmaceuticals, INC. | $16.91 | 2023 | Gvoke Hypopen |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $14.61 | 2024 | Supprelin |
| Insulet Corporation | $14.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ming Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.